TFE3 and renal cell carcinoma: Our findings reveal a novel mechanism whereby a coordinated metabolic shift through the PRCC‐TFE3/HIF1α/SREBP1 axis enhances lipid metabolism, serving as a key step in TFE3‐RCC tumorigenesis.